Luyten GPM - Search Results

1

Two Late Recurrences of Conjunctival Melanoma.

Brouwer NJ, Genders SW, Marinkovic M, van Duinen SG, Jager MJ, Luyten GPM. Brouwer NJ, et al. Among authors: luyten gpm. Ocul Oncol Pathol. 2019 Jun;5(4):262-266. doi: 10.1159/000494978. Epub 2018 Dec 12. Ocul Oncol Pathol. 2019. PMID: 31367588 Free PMC article.

2

Pyrophosphorolysis detects B-RAF mutations in primary uveal melanoma.

Maat W, Kilic E, Luyten GP, de Klein A, Jager MJ, Gruis NA, Van der Velden PA. Maat W, et al. Invest Ophthalmol Vis Sci. 2008 Jan;49(1):23-7. doi: 10.1167/iovs.07-0722. Invest Ophthalmol Vis Sci. 2008. PMID: 18172070

3

Epigenetic regulation identifies RASEF as a tumor-suppressor gene in uveal melanoma.

Maat W, Beiboer SH, Jager MJ, Luyten GP, Gruis NA, van der Velden PA. Maat W, et al. Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1291-8. doi: 10.1167/iovs.07-1135. Invest Ophthalmol Vis Sci. 2008. PMID: 18385040

4

Peptide vaccination after T-cell transfer causes massive clonal expansion, tumor eradication, and manageable cytokine storm.

Ly LV, Sluijter M, Versluis M, Luyten GP, van Stipdonk MJ, van der Burg SH, Melief CJ, Jager MJ, van Hall T. Ly LV, et al. Cancer Res. 2010 Nov 1;70(21):8339-46. doi: 10.1158/0008-5472.CAN-10-2288. Epub 2010 Oct 12. Cancer Res. 2010. PMID: 20940397

5

Shifting exudative age-related macular degeneration patients to ranibizumab after insufficient response to bevacizumab.

de Geus SJ, Jager MJ, Luyten GP, Dijkman G. de Geus SJ, et al. Acta Ophthalmol. 2013 Aug;91(5):e411-3. doi: 10.1111/aos.12090. Epub 2013 Apr 1. Acta Ophthalmol. 2013. PMID: 23551594 Free article. No abstract available.

6

Digital PCR validates 8q dosage as prognostic tool in uveal melanoma.

Versluis M, de Lange MJ, van Pelt SI, Ruivenkamp CA, Kroes WG, Cao J, Jager MJ, Luyten GP, van der Velden PA. Versluis M, et al. PLoS One. 2015 Mar 12;10(3):e0116371. doi: 10.1371/journal.pone.0116371. eCollection 2015. PLoS One. 2015. PMID: 25764247 Free PMC article.

7

Serous Retinopathy Associated with Mitogen-Activated Protein Kinase Kinase Inhibition (Binimetinib) for Metastatic Cutaneous and Uveal Melanoma.

van Dijk EH, van Herpen CM, Marinkovic M, Haanen JB, Amundson D, Luyten GP, Jager MJ, Kapiteijn EH, Keunen JE, Adamus G, Boon CJ. van Dijk EH, et al. Ophthalmology. 2015 Sep;122(9):1907-16. doi: 10.1016/j.ophtha.2015.05.027. Epub 2015 Jun 26. Ophthalmology. 2015. PMID: 26123090 Clinical Trial.

8

Isolated (hypoxic) hepatic perfusion with high-dose chemotherapy in patients with unresectable liver metastases of uveal melanoma: results from two experienced centres.

de Leede EM, Burgmans MC, Kapiteijn E, Luyten GP, Jager MJ, Tijl FG, Hartgrink HH, Grünhagen DJ, Rothbarth J, van de Velde CJ, Verhoef C, Vahrmeijer AL. de Leede EM, et al. Melanoma Res. 2016 Dec;26(6):588-594. doi: 10.1097/CMR.0000000000000286. Melanoma Res. 2016. PMID: 27513071

9

Ruthenium-106 brachytherapy for choroidal melanoma without transpupillary thermotherapy: Similar efficacy with improved visual outcome.

Marinkovic M, Horeweg N, Fiocco M, Peters FP, Sommers LW, Laman MS, Bleeker JC, Ketelaars M, Luyten GP, Creutzberg CL. Marinkovic M, et al. Eur J Cancer. 2016 Nov;68:106-113. doi: 10.1016/j.ejca.2016.09.009. Epub 2016 Oct 12. Eur J Cancer. 2016. PMID: 27741435

10

Ruthenium-106 brachytherapy for iris and iridociliary melanomas.

Marinkovic M, Horeweg N, Laman MS, Bleeker JC, Ketelaars M, Peters FP, Luyten GPM, Creutzberg CL. Marinkovic M, et al. Among authors: luyten gpm. Br J Ophthalmol. 2018 Aug;102(8):1154-1159. doi: 10.1136/bjophthalmol-2017-310688. Epub 2017 Nov 9. Br J Ophthalmol. 2018. PMID: 29122824

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page